Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2010
10/28/2010WO2010121404A1 Bear bile extract and preparation method and use thereof
10/28/2010WO2010083504A3 Therapeutic charge engineered variants of lysozyme and methods for using same to treat infections
10/28/2010WO2010083307A3 Synergistic fungicidal compositions including hydrazone derivatives and copper
10/28/2010WO2010077682A3 Treatment of hiv and aids using probiotic lactobacillus reuteri
10/28/2010WO2010077317A3 Protease inhibitors
10/28/2010WO2010068708A3 3'-azido purine nucleotide prodrugs for treatment of viral infections
10/28/2010WO2010060967A3 Compositions and methods for treating retrovirus infections
10/28/2010WO2010042755A3 Chimeric therapeutics, compositions, and methods for using same
10/28/2010WO2009120789A8 Bicyclic nitroimidazoles covalently linked to substituted phenyl oxazolidinones
10/28/2010US20100274026 Virus therapeutic drug
10/28/2010US20100273977 Process for the preparation of echinocandin derivatives
10/28/2010US20100273890 Identification of bacterial autoinducer and use in treating bacterial pathogenicity
10/28/2010US20100273881 Lipid compositions for the treatment of gastro-intestinal disorders and the promotion of intestinal development and maturation
10/28/2010US20100273876 antibacterial formulation comprising a dialkyl sulphosuccinate and a carbanilide antibacterial agent
10/28/2010US20100273862 Phosphatases which activate map kinase pathways
10/28/2010US20100273861 Mycobacterial peptide deformylase
10/28/2010US20100273859 Treatment and prevention of hiv infection
10/28/2010US20100273850 4-heteroaryl-substituted phenoxyphenylacetic acid derivatives
10/28/2010US20100273847 Desferrioxamine conjugates, derivatives and analogues
10/28/2010US20100273837 Antibacterial agents
10/28/2010US20100273834 Treatment of onychomycosis and related compositions including urea
10/28/2010US20100273826 Methods of use and compositions for the diagnosis and treatment of infectious diseases
10/28/2010US20100273824 Substituted 1,3-dioxanes and their uses
10/28/2010US20100273822 Immediate release compositions and methods for delivering drug formulations using strong acid ion exchange resins
10/28/2010US20100273803 Oral Formulations for Tetrapyrrole Derivatives
10/28/2010US20100273802 New purine derivatives having, in particular, anti-proliferative properties, and their biological uses
10/28/2010US20100273801 Betulin derived compounds useful as antibacterial agents
10/28/2010US20100273792 Macrocyclic indoles as hepatitis c virus inhibitors
10/28/2010US20100273785 2,5-disubstituted arylsulfonamide ccr3 antagonists
10/28/2010US20100273765 Rifamycin analogs and uses thereof
10/28/2010US20100273760 Topical Pharmaceutical Formulations And Methods Of Treatment
10/28/2010US20100273750 Serotonin receptor antagonists for treating arthritis
10/28/2010US20100273748 Antimicrobial therapy
10/28/2010US20100273742 Pharmacologically Active Agents Containing Esterified Phosphonates and Methods for Use Thereof
10/28/2010US20100273740 Phospholipids for the Treatment of Infection by Togaviruses, Herpes Viruses and Coronaviruses
10/28/2010US20100273733 HIV Treatment
10/28/2010US20100273728 Formulations For The Oral Administration of Therapeutic Agents and Related Methods
10/28/2010US20100273726 Methicillin-resistant staphylococcus aureus active metabolites isolated from laurus nobilis and combinations thereof
10/28/2010US20100273705 Method for inhibiting "Melanoma Inhibitory Activity" MIA
10/28/2010US20100273702 Chimerical peptidic molecules with antiviral properties against the viruses of the flaviviridae family
10/28/2010US20100273701 Use of salusin beta alone or in combination with octreotide as a therapeutic agent
10/28/2010US20100273700 Use of a peptide as a therapeutic agent
10/28/2010US20100272838 Compositions comprising siraitia grosvenori extracts and methods for the treatment of infection
10/28/2010US20100272831 Process for manufacturing nanocomposite materials for multisectoral applications
10/28/2010US20100272823 Pulmonary delivery particles comprising water insoluble or crystalline active agents
10/28/2010US20100272818 Compositions and methods comprising terpenes or terpene mixtures selected from thymol, eugenol, geraniol, citral, and l-carvone
10/28/2010US20100272805 Hydrogels for combinatorial delivery of immune-modulating biomolecules
10/28/2010US20100272797 Pharmaceutical Composition for Treating Hepatitis C Virus Infection Comprising HMG-COA Reductase Inhibitor and Bile Acid
10/28/2010US20100272785 Rna sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles
10/28/2010US20100272775 Immobilized biologically active entities having a high degree of biological activity following sterilization
10/28/2010US20100272772 Apparatus, system, and method for creating immunologically enhanced spaces in-vivo
10/28/2010US20100272769 Virus-, Bacteria-, and Fungi-Interacting Layered Phyllosilicates and Methods of Use
10/28/2010US20100272768 Compositions and methods for cell killing
10/28/2010US20100272759 Modified live vaccine of mycoplasma bovis, methods of producing modified live mycoplasma bovis vaccines, combination vaccines and methods of treatment
10/28/2010US20100272758 Viable non-toxic gram-negative bacteria
10/28/2010US20100272757 Bacillus anthracis protective antigen nucleic acid sequences
10/28/2010US20100272756 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
10/28/2010US20100272752 Vaccine for viruses that cause persistent or latent infections
10/28/2010US20100272750 Hpv polyepitope constructs and uses thereof
10/28/2010US20100272749 Optimized expression of HPV 58 L1 in yeast
10/28/2010US20100272748 Vaccine for protection against shigella sonnei disease
10/28/2010US20100272747 Polyvalent chimeric rubella virus-based vaccines
10/28/2010US20100272744 OMP85 Proteins of Neisseria Gonorrhoeae and Neisseria Meningitidis, Compositions Containing Same and Methods of Use Thereof
10/28/2010US20100272736 Combination antibiotic and antibody therapy for the treatment of pseudomonas aeruginosa infection
10/28/2010US20100272735 METHOD TO TREAT USING ANTAGONISTIC ANTI-hTNFSF13B HUMAN ANTIBODIES
10/28/2010US20100272725 Neisserial antigens
10/28/2010US20100272724 Binding molecules capable of neutralizing rabies virus and uses thereof
10/28/2010US20100272720 Antibody Fusion Proteins with a Modified FcRn Binding Site
10/28/2010US20100272706 Antivirals
10/28/2010US20100272683 Heterocyclylaminoalkyl substituted benzimidazoles
10/28/2010US20100272681 Inhibitors of Serine Proteases
10/28/2010US20100272680 Piperidinyl Cyclic Amido Antiviral Agents
10/28/2010US20100272677 Heterocyclic antiviral compounds
10/28/2010US20100272674 Hepatitis C Virus Inhibitors
10/28/2010US20100272670 Biodegradable polyanhydrides with natural bioactive molecules
10/28/2010US20100272639 Polysaccharide nanoparticles
10/28/2010US20100270202 Method of Immunization Against the 4 Dengue Serotypes
10/28/2010CA2759874A1 Methods of treating a pulmonary bacterial infection using fluoroquinolones
10/28/2010CA2759793A1 Preparation and application of the new antibacterial and anticancer compounds and their derivatives
10/28/2010CA2759727A1 Hydrogels for combinatorial delivery of immune-modulating biomolecules
10/28/2010CA2759679A1 Novel compound amycolamicin, method for production thereof, and use thereof
10/28/2010CA2759368A1 5-alkynyl-pyridines
10/28/2010CA2759364A1 Thioxanthene derivatives for the treatment of infectious diseases
10/28/2010CA2759325A1 Replikin-sequences for preventing/treating influenza and determining infectivity/lethality
10/28/2010CA2759146A1 Antibody containing igg2 having amino acid mutation introduced therein
10/28/2010CA2759142A1 Diaryl ethers
10/28/2010CA2758838A1 Heterocyclic antiviral compounds
10/28/2010CA2758644A1 Methods for improving pharmacokinetics
10/28/2010CA2756340A1 Bear bile extract and preparation method and use thereof
10/28/2010CA2755328A1 Use of nifuratel to treat infections caused by atopobium species
10/28/2010CA2744947A1 Use of epidermal growth factor inhibitors in the treatment of viral infection
10/28/2010CA2743801A1 Rifamycin derivatives
10/27/2010EP2243789A1 P.gingivalis antigenic composition
10/27/2010EP2243787A2 Peptides binding the phosphatase 2a protein and polynucleotides encoding same
10/27/2010EP2243786A1 Oligonucleotides against HIV infection and its application in the prevention and treatment of acquired immune deficiency syndrome
10/27/2010EP2243781A1 Pyrazolopyridine derivatives as inhibitors of JAK and CDK2 protein kinases
10/27/2010EP2243493A1 Immunopotentiative composition
10/27/2010EP2243489A2 Therapeutic agent for infections
10/27/2010EP2243485A1 Anti-viral agents, anti-viral fibers and anti-viral fiber structures
10/27/2010EP2243482A1 Use of nifuratel to treat infections caused by atopobium species
1 ... 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 ... 1798